Neoadjuvant chemotherapy
|
4 (16.7%)
|
11 (8.1%)
|
0.247
|
Effective (stable, partial/complete response
|
0 (0.0%)
|
4 (36.4%)
|
0.159
|
Progression
|
4 (100%)
|
7 (63.6%)
| |
Anatomic resectiona
|
7 (29.2%)
|
25 (18.5%)
|
0.269
|
Resection margin (mm)
|
Involved
|
10 (41.7%)
|
20 (14.8%)
|
0.003
|
<10 mm
|
13 (54.2%)
|
85 (63.0%)
| |
≥10 mm
|
1 (4.2%)
|
30 (22.2%)
| |
Recurrence after hepatectomy
|
22 (91.7%)
|
100 (74.1%)
|
0.045
|
Confined in the liver, lung, or both
|
7 (31.8%)
|
31 (31.0%)
|
1.000
|
Recurrence in other distant organ(s)
|
15 (68.2%)
|
69 (69.0%)
| |
Early recurrenceb
|
9 (37.5%)
|
24 (17.8%)
|
0.032
|
Repeated hepatectomy
|
1 (4.2%)
|
13 (9.6%)
|
0.696
|